The invention relates to compound of the formula (I): in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
[EN] COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE<br/>[FR] COMPOSÉS UTILISÉS EN TANT QUE MODULATEURS DE LA BISPHOSPHOGLYCÉRATE MUTASE POUR LE TRAITEMENT DE LA DRÉPANOCYTOSE
申请人:GENZYME CORP
公开号:WO2022056449A1
公开(公告)日:2022-03-17
Provided herein are compounds and compositions thereof for modulating bis-phosphoglycerate mutase (BPGM) for treating sickle cell disease.
本文提供了一种用于调节双磷酸甘油酸酯酶(BPGM)治疗镰状细胞贫血的化合物和其组合物。
Mikrobiologisches Verfahren zur Herstellung von 2-Halo-pyrimidin-4-carbonsäuren
申请人:LONZA AG
公开号:EP0552760A1
公开(公告)日:1993-07-28
Beschrieben werden neue 2-Halo-pyrimidin-4-carbonsäuren der allgemeinen Formel
sowie ein mikrobiologisches Verfahren zur deren Herstellung, ausgehend von einem 2-Halo-4-methylpyrimidin der allgemeinen Formel
Für das Verfahren wird ein Xylol-verwertender Mikroorganismus Pseudomonas putida eingesetzt.
Products of a microbiological process for the production of
申请人:Lonza Ltd.
公开号:US05591853A1
公开(公告)日:1997-01-07
A 2-halo-pyrimidine-4-carboxylic acid of formula: ##STR1## wherein X is a halogen atom, for example, 2-chloro-pyrimidine-4-carboxylic acid. A 2-substituted-pyrimidine-4-carboxylic acid derivative of formula: ##STR2## wherein R.sub.1 is a halogen atom, NH.sub.2 --, HO-- or a C.sub.1 -C.sub.4 alkoxy group and R.sub.2 is a C.sub.1 -C.sub.4 alkoxy group or a halogen atom with the proviso that, if R.sub.1 is a HO-- group, R.sub.2 is not a halogen atom and with the proviso that, if R.sub.2 is a halo group, R.sub.1 is not an amino group. A 2-substituted-pyrimidine-4-carboxylic acid derivative of formula III wherein R.sub.1 is a HO-- group and R.sub.2 is an ethoxy group.